Bal Pharma Limited has clarified that it possesses no undisclosed price-sensitive information or material updates that could account for recent significant fluctuations in its share price.

The company confirmed that all necessary disclosures have been made on time and maintained full compliance with mandatory requirements.

Management stated that the observed stock volatility is entirely market-driven, natural, and independent of any internal company developments or management influence.

This update reassures investors that recent market movements reflect broader conditions rather than operational shifts within the business.